Shares of Spectral Medical Inc. (TSE:EDT – Get Free Report) reached a new 52-week high on Tuesday . The stock traded as high as C$0.79 and last traded at C$0.72, with a volume of 139480 shares changing hands. The stock had previously closed at C$0.75.
Spectral Medical Price Performance
The company has a 50-day moving average of C$0.55 and a 200 day moving average of C$0.58. The company has a debt-to-equity ratio of 26.03, a quick ratio of 0.45 and a current ratio of 0.61. The firm has a market cap of C$205.31 million, a P/E ratio of -10.43 and a beta of 0.96.
Spectral Medical Company Profile
Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation.
Featured Articles
- Five stocks we like better than Spectral Medical
- How to Buy Cheap Stocks Step by Step
- NVIDIA Stock: A Market Barometer in Tech’s Turbulent Times
- The Risks of Owning Bonds
- Palantir Stock Nears Bear Market Territory – Why and What’s Next?
- The 3 Best Blue-Chip Stocks to Buy Now
- Home Depot Turns a Corner: New Highs Likely This Year
Receive News & Ratings for Spectral Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectral Medical and related companies with MarketBeat.com's FREE daily email newsletter.
